OncoSec Medical (NASDAQ:ONCS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “OncoSec Medical Incorporated is a biomedical company engaged in the designing, development and commercialization of therapeutic oncology products. It also develops novel OMS […]
StockNews.com initiated coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a report released on Monday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, BTIG Research reduced their target price on OncoSec Medical from $10.00 to $5.00 and set a “buy” rating on the stock in a report on […]
StockNews.com initiated coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research report released on Sunday. The firm issued a sell rating on the biotechnology company’s stock. Separately, BTIG Research lowered their target price on shares of OncoSec Medical from $10.00 to $5.00 and set a buy rating on the stock in […]
OncoSec Medical (NASDAQ:ONCS – Get Rating) had its target price cut by BTIG Research from $10.00 to $5.00 in a research note released on Wednesday morning, The Fly reports. They currently have a buy rating on the biotechnology company’s stock. Separately, StockNews.com assumed coverage on OncoSec Medical in a research note on Thursday, March 10th. […]